Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
roche
2
×
alexion pharmaceuticals
alnylam pharmaceuticals
biopharma
boehringer ingelheim
clinical trials
dicerna pharamceuticals
duchenne
europe blog main
europe top stories
fda
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
licensing
m&a
muscular dystrophy
patisiran
rna interference
sarepta therapeutics
world health organization
What
gene
2
×
roche
2
×
approval
betting
billion
biopharma
caught
causing
deal
dicerna
disease
drug
duchenne
eye
fda
hepatitis
historic
intended
medicine
medicines
pay
pharma
pharmaceuticals
producing
protein
puts
recently
research
rna
sarepta
second
stop
swiss
team
therapeutics
therapy
won
Language
unset
Current search:
roche
×
roche
×
gene
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
